Continuous Glucose Monitoring (CGM) for Healthy People: Biohacking Trend or a Genuinely Useful Tool?

Continuous glucose monitoring (CGM) systems are small sensors worn on the skin, usually on the arm or abdomen, measuring glucose levels in interstitial fluid every few minutes for 10-14 days. They were developed and validated as a tool for people with type 1 and type 2 diabetes, where they genuinely reduce the risk of dangerous hypoglycemic episodes and help adjust insulin doses — this use has solid, long-standing scientific backing and isn't the subject of this article.

In recent years, CGMs have also reached people without diabetes, promoted by tech companies and health content creators as a tool for 'metabolic optimization' — letting you see in real time how specific meals, sleep, or stress affect your own glucose curve, without waiting for blood test results. This shift from medicine to wellness raises a specific question: does CGM data in someone without diabetes carry useful information, or does it mostly give a false sense of precision where fluctuations are a normal physiological phenomenon?

These numbers are an important reference point for anyone putting on a CGM without diabetes: in a metabolically healthy person, brief excursions above 140 mg/dL after a meal, and even occasional, short dips below 70 mg/dL, fall within normal physiological range rather than being an automatic signal of a metabolic problem. A coefficient of variation below 20% is considered typical of healthy glycemic regulation — another useful reference point when interpreting your own charts.

One of the more reasonable arguments for CGM in select people without overt diabetes is its potential for early detection of carbohydrate metabolism disorders. Standard tests — fasting glucose or hemoglobin A1c (HbA1c) — are time-averaged snapshots and can remain normal in someone who already has abnormal postprandial fluctuations that a single blood test won't catch.

Observational studies suggest that certain glycemic variability parameters measured by CGM, particularly the standard deviation of glucose, may pre-emptively identify people at elevated risk of developing type 2 diabetes in a population without diagnosed disease — a promising but still-developing area of research, requiring further validation before it becomes part of routine prevention for all healthy adults rather than just people with additional risk factors (obesity, family history, metabolic syndrome).

Overinterpreting individual readings can also be a source of unnecessary food-related stress — some CGM users describe growing fear of eating specific, perfectly healthy foods (fruit, for example) just because they see a transient rise on the chart that falls within normal physiological range. This phenomenon, sometimes called data-driven orthorexia, is a real psychological risk of using this kind of tool without the right interpretive context.

CGM in healthy people is a tool with genuine, though still poorly defined, potential — especially where a person has additional metabolic risk factors, and the large individual variability in glycemic response described in the PREDICT 1 study genuinely supports interest in dietary personalization. At the same time, for the average, metabolically healthy person, the benefit of wearing a sensor for a few weeks remains largely unconfirmed by hard data, and the risk of overinterpreting normal physiological fluctuations is real and documented. It's a tool worth considering with a specific research question in mind, not on the assumption that simply wearing a sensor will 'optimize' your health.